Pharmaceutical Product Supply – Triamcinolone Acetonide

The contract entails the supply of 10,000 treatment units of FDA-approved Triamcinolone Acetonide to meet federal pharmaceutical standards, specifically for delivery to a U.S. Navy vessel operating overseas. The product must comply with all required federal specifications for potency, purity, packaging, and labeling to ensure suitability for use in military medical environments. The subcontract falls under NAICS code 325412, indicating classification within pharmaceutical and medicinal product manufacturing, and is administered by the Defense Logistics Agency under the Department of Defense. Delivery is mandated to occur at a location outside the United States, requiring compliance with international shipping regulations and military logistics protocols. The contract was posted on July 21, 2026, and is referenced under the award and delivery identifiers SPE2DX25D8022 and SPE2D926F7496, with all terms governed under DLA’s procurement framework for critical medical supplies.